Ina Allespach

1.0k total citations
13 papers, 843 citations indexed

About

Ina Allespach is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Ina Allespach has authored 13 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 8 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Ina Allespach's work include HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (8 papers) and HIV/AIDS drug development and treatment (7 papers). Ina Allespach is often cited by papers focused on HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (8 papers) and HIV/AIDS drug development and treatment (7 papers). Ina Allespach collaborates with scholars based in Germany, United States and Slovakia. Ina Allespach's co-authors include Oliver T. Keppler, O. Fackler, Hans‐Georg Kräusslich, Nico Michel, Jacomine Krijnse‐Locker, Sonja Welsch, Anja Habermann, Christine Goffinet, Hanna-Mari Tervo and Nadine Tibroni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Current Biology and Journal of Virology.

In The Last Decade

Ina Allespach

13 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ina Allespach Germany 10 652 347 284 225 187 13 843
Stéphanie Wyss United States 6 631 1.0× 231 0.7× 320 1.1× 210 0.9× 144 0.8× 7 715
Beatrice Kramer United Kingdom 6 522 0.8× 247 0.7× 239 0.8× 211 0.9× 359 1.9× 6 844
Johanne Mercier Canada 13 776 1.2× 376 1.1× 290 1.0× 284 1.3× 437 2.3× 15 1.1k
Jennie L. Lovett United States 11 379 0.6× 338 1.0× 110 0.4× 261 1.2× 249 1.3× 18 965
Eduardo Garcia Switzerland 12 580 0.9× 624 1.8× 156 0.5× 266 1.2× 306 1.6× 13 1.1k
William E. Diehl United States 14 346 0.5× 237 0.7× 307 1.1× 205 0.9× 289 1.5× 24 814
Mickaël J. Ploquin France 24 727 1.1× 803 2.3× 263 0.9× 271 1.2× 399 2.1× 38 1.5k
Zachary Klase United States 17 598 0.9× 379 1.1× 391 1.4× 225 1.0× 655 3.5× 37 1.3k
Adarsh Dharan United States 9 483 0.7× 128 0.4× 287 1.0× 142 0.6× 277 1.5× 11 670
Miguel Muñoz Switzerland 20 586 0.9× 330 1.0× 395 1.4× 200 0.9× 568 3.0× 28 1.2k

Countries citing papers authored by Ina Allespach

Since Specialization
Citations

This map shows the geographic impact of Ina Allespach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Allespach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Allespach more than expected).

Fields of papers citing papers by Ina Allespach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Allespach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Allespach. The network helps show where Ina Allespach may publish in the future.

Co-authorship network of co-authors of Ina Allespach

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Allespach. A scholar is included among the top collaborators of Ina Allespach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Allespach. Ina Allespach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Goffinet, Christine, Ina Allespach, Stefanie Homann, et al.. (2009). HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. Cell Host & Microbe. 5(3). 285–297. 221 indexed citations
3.
Kaderali, Lars, et al.. (2009). Biological Signature Characteristics of Primary Isolates from Human Immunodeficiency Virus Type 1 Group O in Ex Vivo Human Tonsil Histocultures. Journal of Virology. 83(20). 10494–10503. 8 indexed citations
4.
Bosch, Valerie, Tanya Pfeiffer, Ina Allespach, et al.. (2009). HIV pseudovirion vaccine exposing Env “fusion intermediates”—Response to immunisation in human CD4/CCR5-transgenic rats. Vaccine. 27(16). 2202–2212. 7 indexed citations
5.
Goffinet, Christine, Ina Allespach, Pamela L. Golden, et al.. (2009). Pharmacovirological Impact of an Integrase Inhibitor on Human Immunodeficiency Virus Type 1 cDNA Species In Vivo. Journal of Virology. 83(15). 7706–7717. 14 indexed citations
6.
Tervo, Hanna-Mari, Ina Allespach, & Oliver T. Keppler. (2008). High-level transfection of primary rabbit T lymphocytes. Journal of Immunological Methods. 336(1). 85–89. 11 indexed citations
7.
Goffinet, Christine, Nico Michel, Ina Allespach, et al.. (2007). Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression. Retrovirology. 4(1). 53–53. 27 indexed citations
8.
Welsch, Sonja, Oliver T. Keppler, Anja Habermann, et al.. (2007). HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages. PLoS Pathogens. 3(3). e36–e36. 215 indexed citations
9.
Goffinet, Christine, Ina Allespach, & Oliver T. Keppler. (2007). HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proceedings of the National Academy of Sciences. 104(3). 1015–1020. 38 indexed citations
10.
Welsch, Sonja, Oliver T. Keppler, Anja Habermann, et al.. (2007). HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages. 2007(Spring). 2 indexed citations
13.
Keppler, Oliver T., et al.. (2005). Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor Nef. Journal of Virology. 79(3). 1655–1665. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026